세팔로스포린 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 3.5%로, 210억 5,000만 달러로 성장합니다. 예측 기간 중의 성장은 전 세계 감염병 부담 증가, 내성균의 출현, 수술 및 의료 관련 감염의 지속적인 증가, 광범위 항생제에 대한 수요 증가 시장 역학에 영향을 미치는 상환 정책의 진화 등에 기인하는 것으로 추정됩니다. 예측 기간 중 주요 동향으로는 기술 발전, 규제 상황, 첨단 솔루션을 통한 시장 확대, 제휴 및 파트너십 등을 들 수 있습니다.
예상되는 감염성 질환 증가가 향후 세팔로스포린 시장의 성장을 촉진할 것입니다. 감염성 질환은 세균, 바이러스, 곰팡이, 기생충 등 병원성 미생물의 침입과 증식으로 인해 발생하는 질병을 포괄합니다. 결핵, 말라리아, 인플루엔자를 포함한 이러한 질병은 세팔로스포린계 항생제 수요에 기여하고 있습니다. 세팔로스포린계 항균제는 다양한 유형의 감염과 관련된 세균 감염의 관리 및 대책에 중요한 역할을 하고 있습니다. 예를 들어 2023년 3월 미국 질병통제예방센터(Centers for Disease Control and Prevention)의 보고에 따르면 미국내 결핵 환자 수가 2021년 7,874명에서 2022년 8,300명으로 증가했습니다. 도달하고 있습니다. 이처럼 감염병의 유행이 확대되고 있는 것이 세팔로스포린 시장의 성장을 가속할 것으로 예상됩니다.
헬스케어 지출 증가는 세팔로스포린 시장의 성장을 가속할 것입니다. 의료 지출에는 보건 서비스, 가족 계획 활동, 영양 프로그램, 건강 중심 긴급 지원 등의 제공과 관련된 모든 비용이 포함됩니다. 의료비 지출 증가는 접근성과 경제성을 향상시키고 항생제 치료의 연구개발 및 혁신을 촉진하여 세팔로스포린 시장에 기여합니다. 메디케어 및 메디케이드 서비스 센터는 2023년 12월 미국의 의료비가 2022년 4.1% 증가한 4조 5,000억 달러, 1인당 1만 3,493달러로 국내총생산의 17.3%를 차지할 것이라고 보고했습니다. 그 결과, 의료비 지출 증가가 세팔로스포린 시장의 성장을 주도하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 세팔로스포린 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 용도 산업의 분석
- 세계의 세팔로스포린 시장 : 성장률 분석
- 세계의 세팔로스포린 시장 실적 : 규모와 성장, 2019-2024
- 세계의 세팔로스포린 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 세팔로스포린 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 세팔로스포린 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 브랜드
- 제네릭
- 세계의 세팔로스포린 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 주사
- 경구
- 세계의 세팔로스포린 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 호흡기 감염증
- 피부 감염증
- 귀 감염증
- 요로감염증
- 성감염증
- 기타 용도
- 세계의 세팔로스포린 시장, 플랫 패널 검출기의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 액티브 매트릭스 플랫 패널 검출기
- 박막 트랜지스터(TFT) 플랫 패널 검출기
- 세계의 세팔로스포린 시장, 이미지 인텐시파이어의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 싱글 필드 이미지 인텐시파이어
- 듀얼 필드 이미지 인텐시파이어
- 세계의 세팔로스포린 시장, 기타 제품 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 전하결합소자(CCD)
- 상보형 금속 산화막반도체(CMOS)
제7장 지역별·국가별 분석
- 세계의 세팔로스포린 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 세팔로스포린 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 세팔로스포린 시장 : 경쟁 구도
- 세팔로스포린 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- AstraZeneca PLC
- Sanofi SA
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Allergan PLC
- Baxter International Inc.
- Eisai Co. Ltd.
- Macleods Pharmaceuticals Ltd
- Sun Pharmaceutical Industries Ltd.
- Shionogi & Co Ltd
- Cipla Inc.
- Hikma Pharmaceuticals PLC
- Lupin Ltd.
- Zydus Lifesciences Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 세팔로스포린 시장 2029 : 새로운 기회를 제공하는 국가
- 세팔로스포린 시장 2029 : 새로운 기회를 제공하는 부문
- 세팔로스포린 시장 2029 : 성장 전략
제36장 부록
KSA
Cephalosporin refers to a class of broad-spectrum, semisynthetic-lactam antibiotics that are widely prescribed to treat diseases caused by both gram-positive and gram-negative bacteria. This class of antibiotics is commonly used to address various infections, including skin infections, strep throat, pneumonia, staph infections, tonsillitis, and bronchitis. Cephalosporins are particularly valuable for individuals allergic to penicillin, another common antibiotic.
The main types of cephalosporins are branded and generic. Branded cephalosporins are antibiotics marketed and sold under a specific brand name by pharmaceutical companies. They are utilized to treat infections caused by susceptible bacteria and can be administered via injection or oral routes. Branded cephalosporins find application in the treatment of respiratory tract infections, skin infections, ear infections, urinary tract infections, sexually transmitted infections, and other medical conditions.
The cephalosporin market research report is one of a series of new reports from The Business Research Company that provides cephalosporin market statistics, including cephalosporin industry global market size, regional shares, competitors with a cephalosporin market share, detailed cephalosporin market segments, market trends and opportunities, and any further data you may need to thrive in the cephalosporin industry. This cephalosporin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cephalosporin market size has grown steadily in recent years. It will grow from $17.69 billion in 2024 to $18.33 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to growing prevalence of bacterial infections, increasing antibiotic resistance, expanding surgical procedures and hospitalizations, rising awareness among healthcare professionals, regulatory support for antibiotic development.
The cephalosporin market size is expected to see steady growth in the next few years. It will grow to $21.05 billion in 2029 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to escalating global burden of infectious diseases, emerging bacterial resistance, continued growth in surgical interventions and healthcare-associated infections, increasing demand for broad-spectrum antibiotics, evolving reimbursement policies influencing market dynamics. Major trends in the forecast period include technological advancements, regulatory landscape, market expansion with advance solution, collaborations and partnerships.
The anticipated increase in infectious diseases is poised to drive the growth of the cephalosporin market in the future. Infectious diseases encompass illnesses caused by the invasion and multiplication of pathogenic microorganisms, such as bacteria, viruses, fungi, and parasites. These diseases, including tuberculosis, malaria, and flu, contribute to the demand for cephalosporin antibiotics. Cephalosporins play a crucial role in managing and combating bacterial infections associated with various types of infections. For example, a report from the Centers for Disease Control and Prevention in March 2023 indicated a rise in tuberculosis (TB) cases in the United States, reaching 8,300 cases in 2022 compared to 7,874 cases in 2021. Thus, the growing prevalence of infectious diseases is expected to fuel the growth of the cephalosporin market.
The increase in healthcare expenditures is set to propel the growth of the cephalosporin market. Healthcare expenditures encompass all costs related to providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. Higher healthcare expenditures contribute to the cephalosporin market by enhancing accessibility and affordability, as well as fostering research, development, and innovation in antibiotic treatments. The Centers for Medicare & Medicaid Services reported in December 2023 that US healthcare spending rose by 4.1% to $4.5 trillion, or $13,493 per person in 2022, accounting for 17.3% of the country's gross domestic product. Consequently, the rise in healthcare expenditures is driving the growth of the cephalosporin market.
Leading companies in the cephalosporin market are actively developing new products and therapies, including advanced-generation cephalosporins, to combat antibiotic resistance and enhance their portfolio's effectiveness against a broader spectrum of bacterial infections. Ceftobiprole, a broad-spectrum cephalosporin antibiotic, is utilized to treat various bacterial infections, including skin and soft tissue infections and pneumonia. Mast Group Ltd. launched Ceftobiprole 5µg in the MASTDISCS Antimicrobial Susceptibility Test range in July 2022, offering a strong alternative for targeted empirical therapy due to its broad range of activity, effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), and favorable safety profile.
In October 2023, the Biomedical Advanced Research and Development Authority (BARDA), a US government department, partnered with Venatorx Pharmaceuticals Inc. This collaboration aims to accelerate the development of innovative medical countermeasures, building on BARDA's track record of supporting over 150 candidates through direct investments and its partnership with the CARB-X program. Venatorx Pharmaceuticals Inc. is a US-based pharmaceutical company focused on developing novel treatments, especially within the cephalosporin class, to combat antibiotic resistance.
Major companies operating in the cephalosporin market report are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Novartis AG, AbbVie Inc., AstraZeneca PLC, Sanofi SA, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Baxter International Inc., Eisai Co. Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Shionogi & Co Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Lupin Ltd., Zydus Lifesciences Ltd., Alkem Labs Ltd., Aurobindo Pharma Ltd., Fresenius Kabi, Aristo Pharmaceuticals Ltd., Accord Healthcare Ltd., Mankind Pharma Ltd., Qilu Anti Pharmaceutical Co. Ltd., Shandong Ruiying Pioneer Pharmaceutical Co. Ltd., Vansen Pharma Inc.
Asia-Pacific was the largest region in the cephalosporin market in 2024. The regions covered in the cephalosporin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cephalosporin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cephalosporin market consists of sales of cefazolin, cefuroxime, cefepime, and ceftriaxone. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cephalosporin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cephalosporin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cephalosporin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cephalosporin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Branded; Generic
- 2) By Route Of Administration: Injection; Oral
- 3) By Application: Respiratory Tract Infection; Skin Infection; Ear Infection; Urinary Tract Infection; Sexually Transmitted Infection; Other Applications
- Subsegments:
- 1) By Flat Panel Detector: Active Matrix Flat Panel Detectors; Thin-Film Transistor (TFT) Flat Panel Detectors
- 2) By Image Intensifier: Single-Field Image Intensifiers; Dual-Field Image Intensifiers
- 3) By Other Product Type: Charge-Coupled Device (CCD); Complementary Metal-Oxide-Semiconductor (CMOS)
- Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; Novartis AG; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cephalosporin Market Characteristics
3. Cephalosporin Market Trends And Strategies
4. Cephalosporin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cephalosporin Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cephalosporin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cephalosporin Market Growth Rate Analysis
- 5.4. Global Cephalosporin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cephalosporin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cephalosporin Total Addressable Market (TAM)
6. Cephalosporin Market Segmentation
- 6.1. Global Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Branded
- Generic
- 6.2. Global Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injection
- Oral
- 6.3. Global Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Other Applications
- 6.4. Global Cephalosporin Market, Sub-Segmentation Of Flat Panel Detector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Active Matrix Flat Panel Detectors
- Thin-Film Transistor (TFT) Flat Panel Detectors
- 6.5. Global Cephalosporin Market, Sub-Segmentation Of Image Intensifier, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-Field Image Intensifiers
- Dual-Field Image Intensifiers
- 6.6. Global Cephalosporin Market, Sub-Segmentation Of Other Product Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Charge-Coupled Device (CCD)
- Complementary Metal-Oxide-Semiconductor (CMOS)
7. Cephalosporin Market Regional And Country Analysis
- 7.1. Global Cephalosporin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cephalosporin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cephalosporin Market
- 8.1. Asia-Pacific Cephalosporin Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cephalosporin Market
- 9.1. China Cephalosporin Market Overview
- 9.2. China Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cephalosporin Market
- 10.1. India Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cephalosporin Market
- 11.1. Japan Cephalosporin Market Overview
- 11.2. Japan Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cephalosporin Market
- 12.1. Australia Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cephalosporin Market
- 13.1. Indonesia Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cephalosporin Market
- 14.1. South Korea Cephalosporin Market Overview
- 14.2. South Korea Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cephalosporin Market
- 15.1. Western Europe Cephalosporin Market Overview
- 15.2. Western Europe Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cephalosporin Market
- 16.1. UK Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cephalosporin Market
- 17.1. Germany Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cephalosporin Market
- 18.1. France Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cephalosporin Market
- 19.1. Italy Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cephalosporin Market
- 20.1. Spain Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cephalosporin Market
- 21.1. Eastern Europe Cephalosporin Market Overview
- 21.2. Eastern Europe Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cephalosporin Market
- 22.1. Russia Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cephalosporin Market
- 23.1. North America Cephalosporin Market Overview
- 23.2. North America Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cephalosporin Market
- 24.1. USA Cephalosporin Market Overview
- 24.2. USA Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cephalosporin Market
- 25.1. Canada Cephalosporin Market Overview
- 25.2. Canada Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cephalosporin Market
- 26.1. South America Cephalosporin Market Overview
- 26.2. South America Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cephalosporin Market
- 27.1. Brazil Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cephalosporin Market
- 28.1. Middle East Cephalosporin Market Overview
- 28.2. Middle East Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cephalosporin Market
- 29.1. Africa Cephalosporin Market Overview
- 29.2. Africa Cephalosporin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cephalosporin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cephalosporin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cephalosporin Market Competitive Landscape And Company Profiles
- 30.1. Cephalosporin Market Competitive Landscape
- 30.2. Cephalosporin Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Cephalosporin Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. Sanofi SA
- 31.3. Takeda Pharmaceutical Company Limited
- 31.4. Eli Lilly and Company
- 31.5. Boehringer Ingelheim International GmbH
- 31.6. Allergan PLC
- 31.7. Baxter International Inc.
- 31.8. Eisai Co. Ltd.
- 31.9. Macleods Pharmaceuticals Ltd
- 31.10. Sun Pharmaceutical Industries Ltd.
- 31.11. Shionogi & Co Ltd
- 31.12. Cipla Inc.
- 31.13. Hikma Pharmaceuticals PLC
- 31.14. Lupin Ltd.
- 31.15. Zydus Lifesciences Ltd.
32. Global Cephalosporin Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cephalosporin Market
34. Recent Developments In The Cephalosporin Market
35. Cephalosporin Market High Potential Countries, Segments and Strategies
- 35.1 Cephalosporin Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cephalosporin Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cephalosporin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
